Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?4.8mm RC, SLA? 14mm, TiZr, Loxim: medical device reports filed with FDA

847 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

847
device reports naming the brand
0% of all MAUDE reports · about 124 a year
184
reports, 12 months to August 2026
136 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

847 medical device reports received by FDA name the brand "BLT ?4.8mm RC, SLA? 14mm, TiZr, Loxim" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

184 reports arrived in the 12 months to August 2026, up 35% from 136 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (68%), loss of osseointegration (16.3%) and difficult to insert (1.8%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01733Sep 2021: 4Oct 2021: 5Nov 2021: 4Dec 2021: 62022Jan 2022: 11Feb 2022: 6Mar 2022: 11Apr 2022: 8May 2022: 14Jun 2022: 16Jul 2022: 4Aug 2022: 13Sep 2022: 6Oct 2022: 9Nov 2022: 1Dec 2022: 82023Jan 2023: 10Feb 2023: 10Mar 2023: 11Apr 2023: 12May 2023: 5Jun 2023: 9Jul 2023: 5Aug 2023: 7Sep 2023: 14Oct 2023: 12Nov 2023: 11Dec 2023: 172024Jan 2024: 6Feb 2024: 5Mar 2024: 12Apr 2024: 7May 2024: 8Jun 2024: 6Jul 2024: 12Aug 2024: 9Sep 2024: 9Oct 2024: 20Nov 2024: 18Dec 2024: 112025Jan 2025: 11Feb 2025: 5Mar 2025: 5Apr 2025: 1May 2025: 0Jun 2025: 33Jul 2025: 11Aug 2025: 12Sep 2025: 6Oct 2025: 21Nov 2025: 15Dec 2025: 112026Jan 2026: 7Feb 2026: 14Mar 2026: 11Apr 2026: 12May 2026: 24Jun 2026: 24Jul 2026: 23Aug 2026: 16

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0661312019: 5620192020: 11020202021: 6620212022: 10720222023: 12320232024: 12320242025: 13120252026: 1312026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%847
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report80.2%679
Voluntary report0%0
User facility report0%0
Distributor report19.8%168
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate57668%62.8%
Loss of osseointegration13816.3%22.4%
Difficult to insertthe device was hard to insert151.8%0.4%
Separation failure40.5%0.1%
Therapeutic or diagnostic output failure10.1%0%
Unintended movement10.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis27732.7%
Painpain, site not specified23027.2%
Tissue damage11813.9%
Hemorrhage/blood loss/bleeding799.3%
Inflammationinflammation677.9%
Swelling/ edema414.8%
Fistula303.5%
Abscessa collection of pus232.7%
Hyperresponsive to stimuli222.6%
Swellingswelling131.5%
Hypersensitivity/allergic reaction80.9%
Failure of implant70.8%
Sinus perforation50.6%
Numbnessnumbness40.5%
Inadequate osseointegration10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?4.8mm RC, SLA? 14mm, TiZr, LoximProduct code DZEAll MAUDE reports
Reports8473,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer80.2%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?4.8mm RC, SLA? 14mm, TiZr, Loxim reports

How many FDA reports name BLT ?4.8mm RC, SLA? 14mm, TiZr, Loxim?

847 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 184 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (68%), loss of osseointegration (16.3%), difficult to insert (1.8%), separation failure (0.5%) and therapeutic or diagnostic output failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (80.2%) and distributor reports (19.8%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?4.8mm RC, SLA? 14mm, TiZr, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.